van der Meij A

Depression Expertise Center, Pro Persona Mental Health Care, Nijmegen, the Netherlands.

5 papers

ArticleKetamine

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.

Lima Constantino J, Freimann TS, van Dalfsen JH +5

Europe PMC2026
ArticleKetamine

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.

Veraart JK, Smith-Apeldoorn SY, van der Meij A +3

Europe PMC2025
ArticleKetamine

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension.

Smith-Apeldoorn SY, Veraart JKE, Kamphuis J +5

Europe PMC2024
ArticleKetamine

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder.

Veraart JKE, van Westenbrugge M, van Wulfften Palthe JE +3

Europe PMC2023
ArticleKetamine

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder

Veraart JKE, van Westenbrugge M, van Wulfften Palthe JE +3

Europe PMC2023